MTOR and central nervous system cancer: Studies have found that NLGN3 secreted by neurons can induce the phosphorylation and activation of several key receptor tyrosine kinases (RTKs) on glioma cells, including focal adhesion kinase activation upstream of PI3K–mTOR [34], thereby promoting glioma progression [35].